CANC vs. BTEC ETF Comparison
Comparison of Tema Oncology ETF (CANC) to Principal Healthcare Innovators Index ETF (BTEC)
CANC
Tema Oncology ETF
CANC Description
Under normal circumstances, the fund seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in publicly listed companies that derive at least 50% of revenues from oncology. The fund is non-diversified.
Grade (RS Rating)
Last Trade
$28.15
Average Daily Volume
4,397
Number of Holdings
*
7
* may have additional holdings in another (foreign) market
BTEC
Principal Healthcare Innovators Index ETF
BTEC Description
The investment seeks to provide investment results that closely correspond, before expenses, to the performance of the Nasdaq Healthcare Innovators Index (the "index"). Under normal circumstances, the fund invests at least 80% of its net assets, plus any borrowings for investment purposes, in equity securities of companies that compose the index at the time of purchase. The index uses a quantitative model designed to identify equity securities in the Nasdaq US Benchmark Index (including growth and value stock) that are small and medium capitalization U.S. healthcare companies.Grade (RS Rating)
Last Trade
$39.49
Average Daily Volume
10,388
Number of Holdings
*
1
* may have additional holdings in another (foreign) market
Performance
Period | CANC | BTEC |
---|---|---|
30 Days | -5.76% | 8.04% |
60 Days | -0.49% | 9.79% |
90 Days | 5.23% | 8.22% |
12 Months | 24.00% | 11.05% |
0 Overlapping Holdings
Symbol | Grade | Weight in CANC | Weight in BTEC | Overlap |
---|
CANC Underweight 1 Positions Relative to BTEC
Symbol | Grade | Weight | |
---|---|---|---|
SCLX | F | -0.09% |
CANC: Top Represented Industries & Keywords
BTEC: Top Represented Industries & Keywords